White Paper

Dario Clinical Research Summary

Dario Clinical Research Summary

Pages 7 Pages

• 26% of users are 65 and older • 1 in 3 users are Black, Asian or Hispanic • 20% of Dario users are from the lowest socioeconomic quintile zip codes • Significant and similar reductions in blood glucose levels measured across different ethnicities, including 14% reduction in average BG levels for white users and 15% reduction for Black, Latino and Asian users. A Market Leader in Clinical Research Dario provides a single, integrated platform that helps people reduce the impact of common chronic conditions—many which occur together—including diabetes, prediabetes, high blood pressure, obesity, pain, stress, anxiety, and depression. Dario is proud of the results its solutions continue to achieve, both in clinical studies and the real world.

Join for free to read